HYPERVARIABLE EPITOPE CONSTRUCTS AS A MEANS OF ACCOUNTING FOR EPITOPE VARIABILITY

被引:20
作者
ANDERSON, DE
MALLEY, A
BENJAMINI, E
GARDNER, MB
TORRES, JV
机构
[1] UNIV CALIF DAVIS,SCH MED,DEPT MICROBIOL & IMMUNOL,DAVIS,CA 95616
[2] UNIV CALIF DAVIS,SCH MED,DEPT PATHOL,DAVIS,CA 95616
[3] OREGON REG PRIMATE RES CTR,BEAVERTON,OR 97006
关键词
HYPERVARIABLE EPITOPE CONSTRUCTS; EPITOPE VARIABILITY; SIMIAN IMMUNODEFICIENCY VIRUS;
D O I
10.1016/0264-410X(94)90225-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Epitope variability is one of the greatest obstacles to development of synthetic peptide vaccines. Based on a recently described hypervariable epitope (aa 414-434) on the envelope glycoprotein (gp130) to simian immunodeficiency virus (SIVmac142), we have developed a novel approach to account for epitope variability. We have prepared, in a single synthesis, a cocktail of peptides, designated a hypervariable epitope construct (HEC), which collectively represent all the in vivo variability seen in an epitope. The HEC represents permutations of amino acid substitutions found in the epitope and has been able to induce antibodies with enhanced binding to native SIV and broad immunoreactivity to related epitope analogues.
引用
收藏
页码:736 / 740
页数:5
相关论文
共 22 条
[1]   STRUCTURAL BASIS OF ANTIGENIC SPECIFICITY AND DESIGN OF NEW VACCINES [J].
ARNON, R ;
VANREGENMORTEL, MHV .
FASEB JOURNAL, 1992, 6 (14) :3265-3274
[2]   SYNTHETIC PEPTIDES AS THE BASIS FOR VACCINE DESIGN [J].
ARNON, R .
MOLECULAR IMMUNOLOGY, 1991, 28 (03) :209-215
[3]   IDENTIFICATION OF A NEUTRALIZING DOMAIN IN THE EXTERNAL ENVELOPE GLYCOPROTEIN OF SIMIAN IMMUNODEFICIENCY VIRUS [J].
BENICHOU, S ;
LEGRAND, R ;
NAKAGAWA, N ;
FAURE, T ;
TRAINCARD, F ;
VOGT, G ;
DORMONT, D ;
TIOLLAIS, P ;
KIENY, MP ;
MADAULE, P .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (06) :1165-1170
[4]   HYPERIMMUNE ANTISERA AGAINST SYNTHETIC PEPTIDES REPRESENTING THE GLYCOPROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 CAN MEDIATE NEUTRALIZATION AND ANTIBODY-DEPENDENT CYTOTOXIC ACTIVITY [J].
BJORLING, E ;
BROLIDEN, K ;
BERNARDI, D ;
UTTER, G ;
THORSTENSSON, R ;
CHIODI, F ;
NORRBY, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (14) :6082-6086
[5]   SELECTION OF GENETIC-VARIANTS OF SIMIAN IMMUNODEFICIENCY VIRUS IN PERSISTENTLY INFECTED RHESUS-MONKEYS [J].
BURNS, DPW ;
DESROSIERS, RC .
JOURNAL OF VIROLOGY, 1991, 65 (04) :1843-1854
[6]  
CALLAHAN KM, 1990, J IMMUNOL, V144, P3341
[7]   CYTOTOXIC LYMPHOCYTE-T (CTL) LOW-RESPONSIVENESS TO THE PLASMODIUM-FALCIPARUM CIRCUMSPOROZOITE PROTEIN IN NATURALLY-EXPOSED ENDEMIC POPULATIONS - ANALYSIS OF HUMAN CTL RESPONSE TO MOST KNOWN VARIANTS [J].
DOOLAN, DL ;
KHAMBOONRUANG, C ;
BECK, HP ;
HOUGHTEN, RA ;
GOOD, MF .
INTERNATIONAL IMMUNOLOGY, 1993, 5 (01) :37-46
[8]  
HAYNES BF, 1993, J IMMUNOL, V151, P1646
[9]   THE GENETIC FATE OF MOLECULARLY CLONED SIMIAN IMMUNODEFICIENCY VIRUS IN EXPERIMENTALLY INFECTED MACAQUES [J].
JOHNSON, PR ;
HAMM, TE ;
GOLDSTEIN, S ;
KITOV, S ;
HIRSCH, VM .
VIROLOGY, 1991, 185 (01) :217-228
[10]   GENETIC-VARIATION OF SIMIAN IMMUNODEFICIENCY VIRUSES IN NONHUMAN-PRIMATES [J].
JOHNSON, PR ;
HIRSCH, VM .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (03) :367-372